Hemin
From Wikipedia, the free encyclopedia
 |
|
|
Hemin
|
|
| Systematic (IUPAC) name | |
| chloro[3,7,12,17-tetramethyl-8,13-divinylporphyrin- 2,18-dipropanoato(2−)]iron(III) |
|
| Identifiers | |
| CAS number | |
| ATC code | B06 |
| PubChem | |
| Chemical data | |
| Formula | C34H32ClN4O4 |
| Mol. mass | 651.94 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | Intravenous infusion |
Hemin (trade name Panhematin) is an iron-containing porphyrin. It is used in the management of porphyria attacks, particularly in acute intermittent porphyria. This should not be confused with Hematin which is Hemoglobin with iron in ferric state.
[edit] External links
- Information from the American Porphyria Foundation, including emergency delivery information
- Hemin at RxList
- MeSH Hemin
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 |
This biochemistry article is a stub. You can help Wikipedia by expanding it. |
